Cargando…
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
BACKGROUND & AIMS: Immunotherapy with hepatitis B virus (HBV)-specific TCR redirected T (HBV-TCR-T) cells in HBV-related hepatocellular carcinoma (HBV-HCC) patients after liver transplantation was reported to be safe and had potential therapeutic efficacy. We aim to investigate the safety of HBV...
Autores principales: | Meng, Fanping, Zhao, Jinfang, Tan, Anthony Tanoto, Hu, Wei, Wang, Si-Yu, Jin, Jiehua, Wu, Juan, Li, Yuanyuan, Shi, Lei, Fu, Jun-Liang, Yu, Shuangjie, Shen, Yingjuan, Liu, Limin, Luan, Junqing, Shi, Ming, Xie, Yunbo, Zhou, Chun-Bao, Wong, Regina Wanju, Lu-En, Wai, Koh, Sarene, Bertoletti, Antonio, Wang, Tingting, Zhang, Ji-Yuan, Wang, Fu-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651587/ https://www.ncbi.nlm.nih.gov/pubmed/34850325 http://dx.doi.org/10.1007/s12072-021-10250-2 |
Ejemplares similares
-
Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC
por: Tan, Anthony Tanoto, et al.
Publicado: (2021) -
HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021) -
Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy
por: Pan, Shida, et al.
Publicado: (2022) -
Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future
por: Koh, Sarene, et al.
Publicado: (2016) -
Challenges of CAR- and TCR-T cell–based therapy for chronic infections
por: Bertoletti, Antonio, et al.
Publicado: (2020)